Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

In patients with Parkinson’s disease (PD), the high risk of mild cognitive impairment (MCI) at the time of diagnosis correlates with low levels of plasma triglycerides (P-TG) and an interaction between change in BMI and P-TG prior to diagnosis, reports a study.

High plasma triglycerides protect patients with PD against cognitive impairment

Frailty linked to increased AF-related hospitalizations in seniors

Older adults with frailty are predisposed to atrial fibrillation (AF)-related hospitalizations, regardless of the presence of multimorbidity, according to a study.

Frailty linked to increased AF-related hospitalizations in seniors

Night light exposure ups cardiovascular risk

Individuals exposed to brighter lights at night have increased risks of incident coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke, according to a study.

Night light exposure ups cardiovascular risk

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

For patients who are struggling to lose weight after metabolic bariatric surgery, treatment with liraglutide boosts weight-loss outcomes and helps avoid conversion surgery, as shown in a randomized clinical trial.

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

PREVENT equations identify individuals who will benefit from intensive SBP control

The reduction in relative risk with intensive vs standard systolic blood pressure (SBP) treatment among individuals without baseline cardiovascular disease (CVD) is consistent across the risk strata using the PREVENT* equations, as shown in the SPRINT study.

PREVENT equations identify individuals who will benefit from intensive SBP control

Bemarituzumab extends survival in FGFR2b-overexpressing gastric cancer

The use of bemarituzumab in combination with chemotherapy provides statistically significant survival benefits among patients with advanced or metastatic FGFR2b-overexpressing gastric or gastroesophageal junction cancer (G/GEJC) in the primary analysis of the phase III FORTITUDE-101 trial.

Bemarituzumab extends survival in FGFR2b-overexpressing gastric cancer

07 Nov 2025

Breastfeeding improves health outcomes in mothers, children

Breastfeeding provides several benefits to mothers and their children, including reduced risks in sudden infant death syndrome and allergic rhinitis, as well as improved physical fitness, reports a study.

Breastfeeding improves health outcomes in mothers, children

Retinal ageing marker may predict cognitive decline, dementia

A study from Singapore underscores the potential of a retinal ageing biomarker derived from retinal photography as a prognostic biomarker for cognitive decline and incident dementia.

Retinal ageing marker may predict cognitive decline, dementia

07 Nov 2025

Postpartum maternal psychological distress tied to neurodevelopmental delay in toddlers

Toddlers born to mothers with psychological distress through 1 year postpartum are more likely to have neurodevelopmental delay, according to a study.

Postpartum maternal psychological distress tied to neurodevelopmental delay in toddlers

First-line sacituzumab govitecan ups PFS in metastatic TBNC

First-line treatment with sacituzumab govitecan, an antibody drug conjugate, significantly improved progression-free survival (PFS) compared with chemotherapy in patients with metastatic triple-negative breast cancer (TNBC), according to the ASCENT-03 trial presented at ESMO 2025.

First-line sacituzumab govitecan ups PFS in metastatic TBNC